When a therapy device takes patient care to the next level, it's an important advancement. When it can also recognize changing patient needs and then automatically make adjustments, it's revolutionary. Philips Respironics BiPAP AVAPS noninvasive ventilator has been developed to help clinicians provide better, more efficient care for patients including children as young as seven years of age and who weigh more than 40 pounds.
Improved patient care, automatic adjustments to meet changing patient needs, plus simplified patient management. And it all comes together in a new lighter, quieter, and easy-to-use device that clinicians and patients are sure to appreciate. Learn more about BiPAP AVAPS technology.
Exclusive benefits for patients... and clinicians
Which patients benefit from AVAPS?
- AVAPS (average volume assured pressure support) automatically adapts to disease progression and changing patient needs
- Maintains optimal patient comfort without compromising patient care and efficacy
- Improves ventilation efficacy*
- Simplifies the titration process
Patients who develop chronic hypoventilation may find BiPAP AVAPS a more comfortable and effective NIV therapy. For example, neuromuscular, COPD, and obesity hypoventilation patients are strong candidates for BiPAP AVAPS.